TerminatedPhase 2NCT02684071

Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors

Studying Atypical teratoid rhabdoid tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Principal Investigator
Ziad Khatib, MD
Nicklaus Children's Hospital
Intervention
Intra thecal methotrexate(drug)
Enrollment
3 enrolled
Eligibility
22 years · All sexes
Timeline
2016 – 2019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02684071 on ClinicalTrials.gov

Other trials for Atypical teratoid rhabdoid tumor

Additional recruiting or active studies for the same condition.

See all trials for Atypical teratoid rhabdoid tumor →

← Back to all trials